Compare OCUL & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCUL | GLOB |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | 2015 |
| Metric | OCUL | GLOB |
|---|---|---|
| Price | $6.29 | $40.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 23 |
| Target Price | $26.00 | ★ $51.18 |
| AVG Volume (30 Days) | ★ 3.5M | 713.6K |
| Earning Date | 11-03-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,990,000.00 | N/A |
| Revenue This Year | $1.71 | N/A |
| Revenue Next Year | $93.12 | $2.18 |
| P/E Ratio | ★ N/A | $22.55 |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $27.56 |
| 52 Week High | $16.44 | $72.10 |
| Indicator | OCUL | GLOB |
|---|---|---|
| Relative Strength Index (RSI) | 26.48 | 64.08 |
| Support Level | $6.23 | $35.32 |
| Resistance Level | $9.93 | $41.44 |
| Average True Range (ATR) | 0.42 | 1.52 |
| MACD | -0.05 | 0.59 |
| Stochastic Oscillator | 15.36 | 94.14 |
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.